News & Updates
Filter by Specialty:
Mirabegron benefits men with OAB, erectile dysfunction
The selective β3-AR agonist mirabegron appears to confer benefits for both overactive bladder (OAB) symptoms and erectile dysfunction (ED) in some patients without compromising safety, as reported in a study.
Mirabegron benefits men with OAB, erectile dysfunction
26 Sep 2022Elobixibat affords metabolic benefits in type 2 diabetes
In type 2 diabetes (T2D) patients with constipation, treatment with elobixibat alleviates constipation while improving glucose metabolism and lowering serum low-density lipoprotein cholesterol (LDL-C) and arachidonic acid (AA) levels, according to the results of a single-arm pilot study.
Elobixibat affords metabolic benefits in type 2 diabetes
25 Sep 2022Does frozen embryo transfer up hypertension risk during pregnancy?
The risk of hypertensive disorders in pregnancy (HDP) is increased following assisted reproductive technology (ART) using frozen embryo transfer (FET) compared with after fresh embryo transfer or natural conception, according to results of a study presented at ESHRE 2022.
Does frozen embryo transfer up hypertension risk during pregnancy?
25 Sep 2022Late-life overweight, obesity may protect against Alzheimer’s
Body mass index in later adulthood appears to be inversely correlated with the incidence of Alzheimer’s disease (AD), a recent study has found. Older adults who are overweight or obese see lower AD risks.